🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2023-03-30
Trial ID
NCT05467670
Treatments Being Tested
This is a multicentric, open-label,non-randomized concurrent control, 1:1 m...
Status
Unknown
Location
Cancer institute
Start Date
2016-12
Trial ID
NCT03123770
Treatments Being Tested
This study is a pilot study of biomarker-driven targeted therapy in patient...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2018-11-26
Trial ID
NCT03699449
This is an open-label, single-arm, phase I/II, single-center study with dos...
Status
Unknown
Location
National University Hospital
Start Date
2020-10-07
Trial ID
NCT04620954
Treatments Being Tested
The objective of this study was to assess the efficacy and safety of the co...
Status
Terminated
Location
Arizona Oncology Associates
Start Date
2021-07-22
Trial ID
NCT04729387
Treatments Being Tested
The overall objective is to demonstrate preliminary efficacy of APX005M-car...
Status
Withdrawn
Location
NSGO-CTU
Start Date
2023-09-07
Trial ID
NCT05201001
Treatments Being Tested
This is a Phase 1b open-label, multicenter study, evaluating the safety, to...
Status
Recruiting
Location
Site 0264
Start Date
2020-10-26
Trial ID
NCT04516447
Treatments Being Tested
The main purpose of this study is to establish the safety and the recommend...
Status
Active Not Recruiting
Location
HonorHealth Research Institute
Start Date
2019-04-26
Trial ID
NCT03872947
This is a therapeutic exploratory Phase 2 study evaluating AEZS-108 compare...
Status
Terminated
Location
University of Miami
Start Date
2012-12
Trial ID
NCT01698281
Treatments Being Tested
This study specifically aims to evaluate how well mocertatug rezetecan (Mo-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-22
Trial ID
NCT07684612